262 related articles for article (PubMed ID: 17589530)
1. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
2. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
3. Current status of leukocyte and platelet administration in cancer therapy.
Walker EM; Cannon A; Mitchum EN
Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
[TBL] [Abstract][Full Text] [Related]
4. [Post-transfusion rise in thrombocytes: observations in a hematologic-oncologic patient sample].
Böck M; Muggenthaler KH; Schmidt U; Heim MU; Mempel W
Infusionsther Transfusionsmed; 1995 Dec; 22(6):350-4. PubMed ID: 8589595
[TBL] [Abstract][Full Text] [Related]
5. Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution.
Gil-Fernández JJ; Alegre A; Fernández-Villalta MJ; Pinilla I; Gómez García V; Martinez C; Tomás JF; Arranz R; Figuera A; Cámara R; Fernández-Rañada JM
Bone Marrow Transplant; 1996 Nov; 18(5):931-5. PubMed ID: 8932847
[TBL] [Abstract][Full Text] [Related]
6. [Ex-vivo bleeding time as a control for platelet transfusion].
Söhngen D; Hattstein E; Heyll A; Kuntz BM; Meckenstock G; Schneider W
Beitr Infusionsther Transfusionsmed; 1994; 32():459-66. PubMed ID: 9480143
[TBL] [Abstract][Full Text] [Related]
7. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation.
Klumpp TR; Herman JH; Innis S; Pearlman E; Culling N; Kotz KW; Slachta C; Goldberg SL; Mangan KF
Bone Marrow Transplant; 1996 Jun; 17(6):1035-41. PubMed ID: 8807111
[TBL] [Abstract][Full Text] [Related]
9. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
Heckman KD; Weiner GJ; Davis CS; Strauss RG; Jones MP; Burns CP
J Clin Oncol; 1997 Mar; 15(3):1143-9. PubMed ID: 9060557
[TBL] [Abstract][Full Text] [Related]
10. Platelet transfusion. Current techniques, remaining problems, and future prospects.
Herman JH; Kamel HT
Am J Pediatr Hematol Oncol; 1987; 9(3):272-86. PubMed ID: 3314551
[TBL] [Abstract][Full Text] [Related]
11. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
[TBL] [Abstract][Full Text] [Related]
12. Platelet kinetics after transfusion.
Saeki Y; Tada K; Sano T; Takahashi Y
Biopharm Drug Dispos; 1996 Jan; 17(1):71-9. PubMed ID: 8991492
[TBL] [Abstract][Full Text] [Related]
13. [Improvement of bleeding tendency and normalized platelet count increment following splenectomy in a patient with refractory anemia].
Kawai Y; Fukushima T; Ookura K; Yoshio N; Yamauchi T; Nakayama T; Tohyama K; Wano Y; Tsutani H; Ueda T; Nakamura T
Rinsho Ketsueki; 1997 Jun; 38(6):532-8. PubMed ID: 9248330
[TBL] [Abstract][Full Text] [Related]
14. The effects of infusion methods on platelet count, morphology, and corrected count increment in children with cancer: in vitro and in vivo studies.
Norville R; Hinds P; Wilimas J; Fairclough D; Fischl S; Kunkel K
Oncol Nurs Forum; 1994; 21(10):1669-73. PubMed ID: 7854929
[TBL] [Abstract][Full Text] [Related]
15. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
[TBL] [Abstract][Full Text] [Related]
16. Platelet transfusion therapy in thrombocytopaenia of haematologic malignancies.
Charak BS; Rao K; Parikh PM; Rawat RS; Nair CN; Advani SH
J Assoc Physicians India; 1989 Mar; 37(3):201-3. PubMed ID: 2768161
[TBL] [Abstract][Full Text] [Related]
17. Platelet transfusion: a dose-response study.
Norol F; Bierling P; Roudot-Thoraval F; Le Coeur FF; Rieux C; Lavaux A; Kuentz M; Duedari N
Blood; 1998 Aug; 92(4):1448-53. PubMed ID: 9694735
[TBL] [Abstract][Full Text] [Related]
18. Clinical and laboratory factors underlying refractoriness to platelet transfusions.
Friedberg RC
J Clin Apher; 1996; 11(3):143-8. PubMed ID: 8915819
[TBL] [Abstract][Full Text] [Related]
19. Conservative management of chemotherapeutic-induced thrombocytopenia in women with gynecologic cancers.
Fanning J; Hilgers RD; Murray KP; Bolt K; Aughenbaugh DM
Gynecol Oncol; 1995 Nov; 59(2):191-3. PubMed ID: 7590471
[TBL] [Abstract][Full Text] [Related]
20. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
